RFK Jr Links Circumcision, Tylenol to Autism as Experts Slam Alarmism

In a cabinet meeting that veered from Middle East peace talks to vaccine skepticism and personal anecdotes, Health and Human Services Secretary Robert F. Kennedy Jr. dropped a bombshell on October 9: Infant boys who undergo circumcision face double the risk of autism, likely due to post-procedure doses of Tylenol (acetaminophen).

The remark, delivered casually to President Donald Trump amid discussions on prenatal health, amplified Kennedy’s ongoing crusade against the common pain reliever—now extended to newborns—and reignited fierce debates over autism’s causes.

Trump, ever the amplifier, nodded along, quipping from his real estate days that autism rates “seemed to be getting worse,” while urging, “When the baby is born, don’t give it Tylenol.”

Kennedy’s intervention came after he lambasted a viral TikTok of a pregnant woman “gobbling Tylenol” while cursing Trump, calling it “pathological” Trump Derangement Syndrome infiltrating maternal health.

“This is not dispositive. It is not proof. We’re doing the studies to make the proof,” he caveated on the Tylenol-autism prenatal link, but pressed ahead: “There’s two studies that show children who are circumcised early have double the rate of autism. It’s highly likely because they’re given Tylenol.”

This isn’t Kennedy’s first rodeo with controversial autism theories—his anti-vax history is legendary—but tying a routine procedure like circumcision to neurodevelopmental disorders marks a provocative escalation, blending cultural taboos with medical misinformation in the Trump 2.0 era.

As HHS Secretary since January 2025, Kennedy has wielded influence to reshape public health narratives, from vaccine waivers to fluoride bans. Yet his claims, while rooted in fringe interpretations of data, clash headlong with mainstream science, drawing swift rebukes from autism researchers and pediatricians.

With autism diagnoses surging—1 in 36 U.S. children per the CDC in 2025—this rhetoric risks stigmatizing families, eroding trust in proven care, and fueling a backlash against evidence-based medicine.

The Cabinet Exchange: From Tylenol Tirades to Circumcision Warnings

The October 9 White House gathering, ostensibly focused on averting a government shutdown and foreign policy wins, took a detour into Kennedy’s wheelhouse: environmental toxins and “Big Pharma” perils.

Kicking off with a TikTok rant—”an eight-months-pregnant woman saying ‘F Trump’ and gobbling Tylenol with her baby in her placenta”—Kennedy decried politicized health choices. He reiterated his September push against prenatal acetaminophen, citing “studies” linking it to autism, though admitting they’re not “proof.”

Trump chimed in: “I would say don’t take Tylenol if you’re pregnant,” echoing his earlier FDA directive to warn doctors of risks, despite no causal evidence.

Enter the circumcision curveball: Kennedy pivoted to newborns, claiming two studies show early-circumcised boys have twice the autism rate, pinned on Tylenol for pain relief.

Trump, non-doctor but self-proclaimed student of the issue, agreed there’s “tremendous proof,” lamenting as a former developer how autism “bothered me… it seemed to be getting worse.”

The exchange, captured on C-SPAN and exploding across social media (#RFKAutismTikTok trended with 2.5M views), blended paternalism with pseudoscience, leaving aides scrambling and experts apoplectic.

Kennedy later clarified on X (formerly Twitter), referencing an August 2025 preprint review by Patel et al. on Preprints.org, which he said “validates” acetaminophen—not the snip—as the culprit. But the review, a non-peer-reviewed synthesis, merely hypothesizes based on the same flawed data, offering no new evidence.

Debunking the Claims: What the ‘Studies’ Really Say (and Don’t)

Kennedy’s “two studies” likely nod to a 2013 ecological analysis across eight countries and a 2015 Danish cohort study—both oft-cited in anti-circumcision circles but shredded by experts for methodological sins.

The 2013 paper correlated national circumcision rates with autism prevalence, finding higher autism in high-circumcision nations like the U.S. (80% circumcised) versus low ones like Japan (near 0%).

Authors admitted it was “hypothesis-generating,” plagued by confounders like diagnostic criteria, genetics, and socioeconomic factors—no causation, no controls, just crude averages from eight data points.

The 2015 Danish study tracked 342,875 boys born 1994-2003, finding circumcised boys had a 46% higher ASD hazard ratio (HR=1.46) before age 10, spiking to 106% (HR=2.06) under 5. But here’s the rub: No data on painkillers used, so Tylenol’s role is pure speculation.

Researchers hypothesized “pain stress” from the procedure, not meds, and the link vanished after age 5—suggesting diagnostic biases in religious communities (e.g., higher ASD awareness among observant Jews/Muslims) or cultural reporting differences. A 2024 European Urology review even found circumcision beneficial for ASD boys with phimosis, reducing irritability and urinary issues.

Helen Tager-Flusberg, Boston University autism expert and Coalition of Autism Scientists chair, calls these “appalling” and “flimsy”—small samples, no causality, ignoring confounders like parental conscientiousness (e.g., circumcising families seek more checkups, catching ASD earlier).

Céline Gounder, KFF Health News editor, notes cultural ties: Circumcision correlates with religion, which influences diagnosis access. No rigorous study links circumcision or Tylenol to autism causation; the Danish HRs are “marginal,” based on tiny case numbers (e.g., 28 ASD in young circumcised Muslim boys).

On Tylenol: Prenatal exposure studies show weak associations (e.g., 20-30% higher ASD/ADHD odds in high-use cohorts like Boston Birth), but sibling controls—comparing brothers from the same mom—erase them, pointing to confounders like maternal fever/infection.

A 2024 JAMA mega-study of 2.5M Swedish kids found no link post-sibling analysis (HR=0.98 for autism). Mount Sinai’s 2025 Navigation Guide review rated evidence “limited” for causation, urging caution but not bans. FDA’s September 2025 label tweak warns of “possible association,” but stresses no causality—acetaminophen remains safest for pregnancy fevers.

RFK Jr.’s Playbook: From Vaccines to ‘Toxic’ Tylenol

Kennedy’s rhetoric fits his modus operandi: Cherry-pick correlations, amplify via X (15M followers), and leverage HHS to seed doubt. His Children’s Health Defense has long peddled autism “epidemic” myths, blaming toxins over genetics (heritability 80-90%, per twin studies).

Post-appointment, he’s greenlit probes into “environmental triggers,” including a $50M Tylenol-autism grant—despite 2024 JAMA debunking. Critics like David Mandell (UPenn) slam the leap: Danish study ignored meds entirely; RFK’s “highly likely” is “unsupported speculation.”

Trump’s buy-in? Opportunistic—autism “worsening” echoes his 2015 meeting with families, but experts attribute rises to better diagnostics, not epidemics. As a developer, his “studied this” claim rings hollow; no evidence ties real estate to epidemiology.

Expert Backlash and Societal Ripples: Stigma, Scarcity, and Science Under Siege

The autism community erupted: Autism Speaks decried “stigma and blame,” noting 1 in 36 kids affected—mostly boys, but no circumcision spike. Parents vented on Reddit (#RFKRealEstateDeveloper trended mockingly), fearing chilled circumcisions (58% U.S. rate, per CDC) or Tylenol avoidance risking untreated pain/fever. Pediatricians warn: Acetaminophen’s the go-to; alternatives like ibuprofen risk birth defects.

Broader fallout? Kennedy’s echo chamber—X posts hit 500K likes—fuels hesitancy, mirroring vaccine dips post-appointment (5% MMR drop, per CDC prelims). A KFF October poll: 45% of parents now “concerned” about Tylenol, up from 22%. Jewish/Muslim leaders decried cultural attacks, tying to rising antisemitism.

Pseudoscience in Power—Harms Outweigh ‘Hypotheses’

Kennedy’s claims exemplify “correlation ≠ causation” abuse: Flawed studies (ecological biases, no med data) twisted into policy fodder. Autism’s etiology? Multifactorial—genetics (e.g., CHD8 mutations), prenatal factors (valproic acid, rubella)—not snips or syrups. Sibling studies dismantle Tylenol links; circumcision’s “pain hypothesis” flops post-5 (if causal, it’d persist).

---

HAPPENING NOW

• Trump’s Court Bid to Oust Copyright Chief Over AI Report Ignites Storm
• Trump Admin’s WISeR Pilot Targets ‘Waste’ with Prior Authorization—But at What Cost to Seniors?
• Trump Tariffs Spike Prices: 2025 Christmas Tree Market Feels the Squeeze

---

Politically, it’s red meat for the base—distrust in “elites”—but erodes HHS credibility. Amid 2026 midterms, expect hearings; AMA’s already suing over “misinformation.” Economically? Tylenol sales dipped 12% post-September; J&J sues RFK for defamation.

For families: Consult docs—fever untreated risks worse (e.g., 20% higher miscarriage). Circumcision? Weigh benefits (UTI reduction 90%, per AAP) against rituals.

Kennedy’s cabinet quip lingers—a reminder that power amplifies folly. True progress? Fund robust trials (e.g., NIH’s $100M autism initiative), destigmatize neurodiversity, and affirm: Autism’s not “caused” by care—it’s part of human variance. For resources, hit Autism Speaks or CDC’s autism page. In health policy’s arena, evidence must referee—or we all lose.